Estrogen receptor mutations in tamoxifen-resistant breast cancer.

Clinical resistance to antiestrogens like tamoxifen is a major problem in the treatment of hormone-dependent breast cancers. Since the estrogen receptor plays a central role in mediating the effects of estrogens and antiestrogens, we hypothesized that mutations in the estrogen receptor could be one mechanism by which breast tumors evolve from a hormone-dependent to a hormone-independent phenotype. The eight exons of the estrogen receptor complementary DNA from 20 tamoxifen-resistant and 20 tamoxifen-sensitive tumors were screened by Single Strand Conformation Polymorphism (SSCP), and the variant conformers were sequenced to identify the nucleotide changes. A 42-base pair replacement was found in exon 6 of a tamoxifen-resistant tumor. A single base pair deletion in exon 6 of a tamoxifen-resistant metastatic tumor but not in the primary tumor was detected in another case. If translated, both these mutations could generate truncated receptors with an intact DNA-binding domain and a defective hormone-binding domain that could constitutively activate transcription of previously estrogen-responsive genes. The remaining 18 of 20 tamoxifen-resistant tumors did not contain mutations in any of the 8 exons of the estrogen receptor complementary DNA. These results suggest that mutations in the estrogen receptor occur at a low frequency and do not account for most estrogen-independent, tamoxifen-resistant breast tumors.

[1]  W. Jonat,et al.  The problem of nonresponding estrogen receptor‐positive patients with advanced breast cancer , 1980, Cancer.

[2]  P. Chambon,et al.  A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas , 1990, Nature.

[3]  J. Deslypere,et al.  Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. , 1992, Molecular endocrinology.

[4]  W. McGuire,et al.  Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. , 1992, Cancer research.

[5]  F. S. French,et al.  Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Isaacs,et al.  Androgen receptor gene mutations in human prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Cotton,et al.  Detection of single base changes in nucleic acids. , 1989, The Biochemical journal.

[8]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[9]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.

[10]  P. Chambon,et al.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. , 1989, The EMBO journal.

[11]  B. O’Malley,et al.  Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. , 1988, Science.

[12]  R. Simon,et al.  Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. , 1980, European journal of cancer.

[13]  P. Chambon,et al.  Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D. , 1990, Cancer research.

[14]  C. Benz,et al.  Truncated forms of DNA-binding estrogen receptors in human breast cancer. , 1991, The Journal of clinical investigation.

[15]  W. McGuire,et al.  Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.

[16]  J. Northrop,et al.  Analysis of glucocorticoid unresponsive cell variants using a mouse glucocorticoid receptor complementary DNA clone. , 1986, The Journal of biological chemistry.

[17]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[18]  W. McGuire,et al.  Current status of estrogen and progesterone receptors in breast cancer , 1977, Cancer.

[19]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.